Skip to main content

Table 2 Demography, clinical, and laboratory data comparison between mono-infection and concurrent infections cases during dengue surveillance in Bali

From: Concurrent infections of dengue virus serotypes in Bali, Indonesia

Variable

Mono-infection cases (N = 182)

Concurrent infections cases (N = 8)

Demography and clinical manifestations

Age, median year (range)

28 (14–75)

42 (25–53)

Male, N (%)

80 (44.0)

7 (87.5)

Female, N (%)

102 (56.0)

1 (12.5)

Fever day, days ± SD

3.3 ± 0.83

2.0 ± 0.93

Headache

139 (76.4)

7 (87.5)

Arthralgia

101 (55.5)

6 (75.0)

Myalgia

122 (67.0)

6 (75.0)

Vomiting

92 (50.5)

2 (25.0

Bleeding

46 (25.3)

2 (25.0)

Plasma leakage

0 (0.0)

0 (0.0)

Shock

0 (0.0)

0 (0.0)

Laboratory examinations data

Nadir WBC (× 10 µg/µL), median (range)

2.1 (0.48–6.4)

2.77 (1.16–4.1)

HCT difference (%), median (range)

13.1 (2.43–68.9)

11.5 (6.1–21.4)

Nadir PLT (× 109/L), median (range)

43 (6–194)

102 (16–122)

DENV NS1 test positivity, N (%)

173 (95.1)

8 (100.0)

Dengue IgM positivity, N (%)

123 (67.6)

7 (87.5)

Dengue IgG positivity, N (%)

142 (78.0)

5 (62.5)

Dengue severity

DF, N (%)

110 (60.4)

6 (75.0)

DHF grade 1, N (%)

42 (23.1)

2 (25.0)

DHF grade 2, N (%)

26 (14.3)

0 (0.0)

DHF grade 3, N (%)

4 (2.2)

0 (0.0)

DHF grade 4, N (%)

0 (0.0)

0 (0.0)

  1. DF, dengue fever; DHF, dengue hemorrhagic fever; WBC, white blood cell; HCT, hematocrit; PLT, platelet